Today’s Pharma Digest – January’ 16th, 2019

Sanofi expands multitargeting toolbox with Biomunex deal

Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there’s no connection

Tribe, Allergan appeal sovereign immunity patent case to Supreme Court

Copay coupons help (a little) with CV drug adherence but not outcomes: study

Walgreens CEO: Microsoft Will Help Create ‘Ecosystem’ To Simplify Healthcare

Bioharmony, Boehringer partner to develop antimicrobials

‘A blizzard of prescriptions’: Documents reveal new details about Purdue’s marketing of OxyContin

FDA drug reviews running on fumes

Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices

AI Picks Out ‘Shapeshifting’ Cancer Cells, Revealing Potential New Drug Targets

Harvard prof David Sinclair backs anti-aging upstart Life Bio, which just raised $50M for research

As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations

Want to win over payers, pharma? Forget the ‘me-too’ drugs, CSL chief says

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica

Attendees fed up with venue, high prices call to move JPM out of San Francisco

The Demise Of A Once Promising Pancreatic Cancer Drug Is All Too Common

Aimmune says shutdown blocks peanut allergy drug review

Merck’s Keytruda slashes death risk by 31% in esophageal cancer victory

Purdue appeals order to unseal OxyContin records to Kentucky Supreme Court

 

Subscribe to Read More…

Click here to Subscribe

 

Psychosis patients waiting for NHS treatment

Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It’s So Hard

Jefferies upgrades Sun Pharma to buy

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

Allergan and a Mohawk tribe ask the Supreme Court to review their controversial patent deal

FDA-approved drug hampers cancer metastasis in animal model, shows study

Keele University awarded over £2m to investigate opioid overprescribing

Gottlieb, Marks detail plans to advance development of cell and gene therapies

As you age, learn to say no — it’s good for your health

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for eleven markets in Asia Pacific

Psychosis patients waiting for NHS treatment

‘Professional Standards for Community Pharmacy Services’ to be set

After 37 years of trying, this biotech nears a first drug approval in breast cancer

Preparing PIs for post EU-FMD success

Innovation in flu vaccination

Providing Succour To Nigerian Farmers Through Biotechnology

Is strong growth ahead for Diageo plc, easyJet plc, AstraZeneca plc and WM Morrison…

Supporting POYC medicines verification

Most substance use disorder treatment facilities do not offer medication treatment

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

FDA-approved drug hampers cancer metastasis in animal model, shows study

Jefferies upgrades Sun Pharma to buy

Catabasis Pharmaceuticals: My Long Thesis And Analysis

Aurinia Offers A Lot Of Upside Potential With Upcoming Phase 2 Dry Eye Disease Study Readout

Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It’s So Hard

New, scalpel-free treatment for reducing Parkinson’s tremor gets FDA approval

 

Advertisements

Today’s Pharma Digest – January’ 8th, 2019

AstraZeneca loses two senior executives as biotechs appoint new CEOs

Eli Lilly to buy Loxo Oncology in deal worth $8 billion

GlaxoSmithKline CEO Emma Walmsley gets ‘radical’ about reshaping portfolio

GSK CEO: Pfizer venture creates value for both our consumer and pharma businesses

AstraZeneca names controversial cancer scientist José Baselga to a top R&D post in major shakeup

Celgene execs whipped up new pay packages ahead of BMS deal

BSE Pharma index up led by Sun Pharma, Aurobindo

Share market update: Pharma shares advance; Sun Pharma jumps over 2%

CMB International Leads $100M Series B Round Into US Biopharmaceutical Firm

Poseida Therapeutics: Great Results, But At An Early Stage Of Development

3 Big 2019 FDA Decisions And Their Effect On These Biotechs

“Science Favors J&J in Talcum Powder Lawsuits”

Rising drug prices linked to older products, study finds

Brace yourself: This is the only job in America that pays six figures and has low levels of stress

Click here to Subscribe

Pharma Top Headlines _ January’ 2019

  • Merck to license investigational insulin sensitizer, NGM313 from NGM Bio to treat NASH and type 2 diabetes       (Click here to Subscribe)

 

  • NIH study shows proximity to muscle cells may promote spread of prostate cancer cells       (Click here to Subscribe)

 

  • China’s NMPA grants priority review designation to Eisai’s NDA for perampanel       (Click here to Subscribe)

 

  • Biogen starts phase 3b study to evaluate EID with natalizumab in multiple sclerosis       (Click here to Subscribe)

 

  • UK MHRA recalls Irbesartan blood pressure and heart medication from pharmacies due to possible NDEA contamination       (Click here to Subscribe)

 

  • Gujarat based pharma cos propose big ticket investments worth Rs. 3,703.61 crore       (Click here to Subscribe)

 

  • Five-year price control exemption for new medicines to give rare disease patients access to orphan drugs       (Click here to Subscribe)

 

  • Indian healthcare sector expects private-public partnerships to spur expansion of services in 2019       (Click here to Subscribe)

 

  • Telangana state growing as life sciences and biotech sector leader in India: Shakti Nagappan       (Click here to Subscribe)

 

  • Maha FDA files 3 more FIRs against unscrupulous drug dealers for trading immunoglobulin injections in open market       (Click here to Subscribe)

 

  • Govt cracks whip on misleading ASU drug ads; mandatory unique ID number introduced to tackle fraudsters       (Click here to Subscribe)

 

  • Severe shortage of faculty in medical colleges hits quality of education in teaching hospitals       (Click here to Subscribe)

 

  • Scores of traders in UP land in soup after recovery of huge quantity of pain killer spasmo-proxyvon plus capsules       (Click here to Subscribe)

 

  • India to collaborate with London School of Economics for global research project on dementia       (Click here to Subscribe)

 

  • Gujarat FDCA detects case of spurious herbal drug in circulation in Vadodara, Ahmedabad to treat joint pain       (Click here to Subscribe)

 

  • New public procurement policy for formulations to foster MSME growth; industry groups seek effective implementation       (Click here to Subscribe)

 

  • Even after four year, state govts yet to amend NDPS Act to bring it at par with Central Act       (Click here to Subscribe)

 

  • AGPH urges Central govt to bring legislation to enforce mandatory installation of ACs in all pharmacies to ensure safety of drugs       (Click here to Subscribe)

 

  • IPC to develop information sharing portal to ensure safe medical devices in the country       (Click here to Subscribe)

 

  • Indian Pharmaceutical Association asks PCI to develop dedicated curriculum for D Pharm Exit Examination       (Click here to Subscribe)

 

  • Govt moots initiative to double market share of biosimilars; biotech firms, research institutes to get fund boost       (Click here to Subscribe)

 

  • BSE Healthcare index underperforms to BSE Sensex in 2018 and close at 13,923.37 points       (Click here to Subscribe)

 

  • CPA urges Chhattisgarh govt to create promotional cadres; wants appointment of pharmacists in all sub-centres       (Click here to Subscribe)

 

  • Experts advocate technologies like Artificial Intelligence for better healthcare accessibility       (Click here to Subscribe)

 

  • CBR, NIMHANS, IISc & SDUMC collaborate to assess & prevent neuro cognition impairment in ageing population       (Click here to Subscribe)

 

  • Govt soon to issue guidance document for veterinary biologicals to fast-track licensing & field trials of vaccines & drugs       (Click here to Subscribe)

 

  • Maha FDA to take action against gamma irradiation plants running without cold storage facilities       (Click here to Subscribe)

 

  • IPA to act against defunct state and local branches; state branch of Odisha IPA derecognized       (Click here to Subscribe)

 

  • MCI to issue notification to remove anomaly in qualification for appointment of asst professors in non-clinical subjects       (Click here to Subscribe)

 

  • Lifescience tech experts view smart medical devices with AI & blockchain to boost patient care & monitor cyber security threats       (Click here to Subscribe)

 

 

  • Pfizer starts phase 2b/3 trial for oral JAK3 inhibitor, PF-06651600 to treat moderate to severe alopecia areata       (Click here to Subscribe)

 

  • Aevi Genomic Medicine ASCEND trial of AEVI-001 in children with ADHD fails to meet primary endpoint       (Click here to Subscribe)

 

  • Bristol-Myers Squibb to buy New Jersey-based global biopharma company, Celgene for $74 billion       (Click here to Subscribe)

 

  • BrainScope gets US FDA clearance for multi-modal, multi-parameter concussion assessment       (Click here to Subscribe)

 

 

 

 

  • CSI receives Japanese approval for Diamondback 360 Coronary OAS with Classic Crown & ViperWire Advance Coronary Guidewire FlexTip       (Click here to Subscribe)

 

  • Adlai Nortye, Merck ink clinical collaboration to evaluate safety & efficacy of AN002 and Keytruda combo in patients with solid tumors       (Click here to Subscribe)

 

  • Scientus Pharma gets Health Canada approval for sale of dried cannabis for medical purposes       (Click here to Subscribe)

 

  • Teva, Amgen settle generic cinacalcet HCl product patent infringement litigation       (Click here to Subscribe)

 

  • Eris Lifesciences collaborates with Medtronic for diabetes monitoring initiative       (Click here to Subscribe)

 

  • Cabinet approves restructuring of National Health Agency as National Health Authority       (Click here to Subscribe)

 

  • Union chemicals minister DV Gowda to inaugurate 2-day global pharma, medical device meet in Bengaluru on Feb-18       (Click here to Subscribe)

 

 

  • Luminex completes acquisition of MilliporeSigma’s flow cytometry portfolio       (Click here to Subscribe)

 

  • Intec Pharma begins patient dosing in phase 1 PK study of Accordion Pill-THC       (Click here to Subscribe)

 

  • HJB merges with MabSpace to create fully integrated global biotherapeutics company, Transcenta Holding       (Click here to Subscribe)